14-50632302-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_015915.5(ATL1):c.1640C>T(p.Ser547Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000992 in 1,613,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. S547S) has been classified as Likely benign.
Frequency
Consequence
NM_015915.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL1 | NM_015915.5 | c.1640C>T | p.Ser547Leu | missense_variant | 14/14 | ENST00000358385.12 | NP_056999.2 | |
ATL1 | NM_001127713.1 | c.1625C>T | p.Ser542Leu | missense_variant | 14/14 | NP_001121185.1 | ||
ATL1 | NM_181598.4 | c.1625C>T | p.Ser542Leu | missense_variant | 13/13 | NP_853629.2 | ||
ATL1 | XM_047431430.1 | c.1640C>T | p.Ser547Leu | missense_variant | 15/15 | XP_047287386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATL1 | ENST00000358385.12 | c.1640C>T | p.Ser547Leu | missense_variant | 14/14 | 1 | NM_015915.5 | ENSP00000351155.7 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250870Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135564
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461012Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 726856
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74292
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 3A Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 12, 2021 | This sequence change replaces serine with leucine at codon 547 of the ATL1 protein (p.Ser547Leu). The serine residue is moderately conserved and there is a large physicochemical difference between serine and leucine. This variant is present in population databases (rs778692077, ExAC 0.01%). This missense change has been observed in individual(s) with clinical features of autosomal dominant ATL1-related conditions (Invitae). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATL1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at